[1]
Brusamolino, E. et al. 2012. THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY. Mediterranean Journal of Hematology and Infectious Diseases. 4, 1 (Apr. 2012), e2012022. DOI:https://doi.org/10.4084/mjhid.2012.022.